Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail

被引：5
|
作者：
Daylan, Ayse Ece Cali [1 ]
Halmos, Balazs [1 ]
机构：
[1] Montefiore Med Ctr, Dept Oncol, 111 E 210th St, Bronx, NY 10467 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2023年 / 12卷 / 07期
关键词：
Immunotherapy; metastatic; non-small cell lung cancer (NSCLC); pembrolizumab; PHASE-III; OPEN-LABEL; CHEMOTHERAPY; PEMBROLIZUMAB; IPILIMUMAB;
D O I：
10.21037/tlcr-23-245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1636 / 1642
页数：7
相关论文
共 50 条
  • [1] Characterization of patients with metastatic non-small cell lung cancer obtaining long term benefit from immunotherapy
    Galli, G.
    Proto, C.
    Signorelli, D.
    Imbimbo, M.
    Ferrara, R.
    Prelaj, A.
    De Toma, A.
    Randon, G.
    Trevisan, B.
    Ganzinelli, M.
    Zilembo, N.
    Garassino, M. C.
    Lo Russo, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 56 - 56
  • [2] Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
    Galli, Giulia
    Proto, Claudia
    Signorelli, Diego
    Imbimbo, Martina
    Ferrara, Roberto
    Prelaj, Arsela
    De Toma, Alessandro
    Ganzinelli, Monica
    Zilembo, Nicoletta
    de Braud, Filippo
    Garassino, Marina C.
    Lo Russo, Giuseppe
    FUTURE ONCOLOGY, 2019, 15 (23) : 2743 - 2757
  • [3] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [4] Complications of immunotherapy in the course of long-term response in a patient with non-small cell lung cancer
    Gorzelak-Magiera, Anita S.
    Domagala-Haduch, Malgorzata
    Gisterek-Grocholska, Iwona
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [5] Long-Term Survival in Metastatic Non-Small Cell Lung Cancer: Predictive Clinical Factors
    Boente, Leonardo A.
    Da Costa, Alexandre A. B. A.
    Pereira, Augusto A. R.
    Gonzaga, Talita
    Fares, Aline F.
    Araujo, Daniel V.
    Garcia, Daniel
    Lacerda, Daniela
    Fanelli, Marcello F.
    Rinck, Jose A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S652 - S652
  • [6] Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
    Nadal, Ernest
    Massuti, Bartomeu
    Domine, Manuel
    Garcia-Campelo, Rosario
    Cobo, Manuel
    Felip, Enriqueta
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (03) : 341 - 352
  • [7] Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
    Ernest Nadal
    Bartomeu Massuti
    Manuel Dómine
    Rosario García-Campelo
    Manuel Cobo
    Enriqueta Felip
    Cancer Immunology, Immunotherapy, 2019, 68 : 341 - 352
  • [8] Basal lymphopenia as a potential predictor of benefit from immunotherapy in metastatic non-small cell lung cancer
    Galli, G.
    Poggi, M.
    Fuca, G.
    Lo Russo, G.
    Proto, C.
    Signorelli, D.
    Vitali, M.
    Ganzinelli, M.
    Zilembo, N.
    de Braud, F.
    Garassino, M. C.
    Imbimbo, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib
    Nakatomi, K
    Soda, H
    Kitazaki, T
    Nakano, H
    Uchida, K
    Urabe, S
    Nakamura, Y
    Hayashi, T
    Tsukamoto, K
    Kohno, S
    LUNG CANCER, 2006, 52 (02) : 253 - 255
  • [10] Long-term outcomes of completion pneumonectomy for non-small cell lung cancer
    Sezen, Celal Bugra
    Kocaturk, Celalettin Ibrahim
    Bilen, Salih
    Kalafat, Cem Emrah
    Aker, Cemal
    Karapinar, Kemal
    ACTA CHIRURGICA BELGICA, 2019, 119 (05) : 303 - 308
12345